Association study of NRXN3 polymorphisms with schizophrenia and risperidone-induced bodyweight gain in Chinese Han population

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 43, Issue , 2013, Pages 197-202

  Hu, Xiaofeng ^a,b   Zhang, Jishui ^c   Jin, Chao ^d   Mi, Weifeng ^a,b   Wang, Fang ^a,b   Ma, Wenbin ^d   Ma, Cuicui ^d   Yang, Yongfeng ^e,f   Li, Wenqiang ^e,f   Zhang, Hongxing ^e,f   Du, Bo ^g   Li, Keqing ^g   Liu, Chenxing ^a,b   Wang, Lifang ^a,b   Lu, Tianlan ^a,b   Zhang, Hongyan ^a,b   Lv, Luxian ^e,f   Zhang, Dai ^a,b   Yue, Weihua ^a,b  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b BEIJING HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Jinzhou Kangning Hospital   (China)

^e XINXIANG MEDICAL UNIVERSITY   (China)

^f Henan Mental Hospital   (China)

^g Hebei Mental Health Center   (China)

Author keywords

Antipsychotics; Neurexin 3 (NRXN3); Schizophrenia

Indexed keywords

ADENINE; CYTOSINE; RISPERIDONE; THYMINE;

ADULT; ARTICLE; CHINESE; CHINESE HAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUREXIN 3 GENE; PHARMACOGENETICS; POPULATION GENETICS; POPULATION RESEARCH; SCHIZOPHRENIA; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; DNA; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISPERIDONE; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 84873843238     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.12.007     Document Type: Article

References (48)

1. Allison D.B., Mentore J.L., Heo M., Chandler L.P., Cappelleri J.C., Infante M.C., et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999, 156(11):1686-1696.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
3. Bayer T.A., Falkai P., Maier W. Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". J Psychiatr Res 1999, 33(6):543-548.
4. Bierut L.J., Madden P.A.F., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O.F., et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 2007, 16(1):24-35.
5. Brown S.M., Clapcote S.J., Millar J.K., Torrance H.S., Anderson S.M., Walker R., et al. Synaptic modulators Nrxn1 and Nrxn3 are disregulated in a Disc1 mouse model of schizophrenia. Mol Psychiatry 2011, 16(6):585-587.
6. Budreck E.C., Scheiffele P. Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. Eur J Neurosci 2007, 26(7):1738-1748.
7. Cannon T.D., Kaprio J., Lonnqvist J., Huttunen M., Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort: a population-based modeling study. Arch Gen Psychiatry 1998, 55(1):67-74.
8. Caspi A., Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 2006, 7(7):583-590.
9. Chen X., Liu H., Shim A.H.R., Focia P.J., He X. Structural basis for synaptic adhesion mediated by neuroligin-neurexin interactions. Nat Struct Mol Biol 2008, 15(1):50-56.
10. Chih B., Gollan L., Scheiffele P. Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex. Neuron 2006, 51(2):171-178.
11. Chubykin A.A., Liu X., Comoletti D., Tsigelny I., Taylor P., Südhof T.C. Dissection of synapse induction by neuroligins. J Biol Chem 2005, 280(23):22365-22374.
12. Craig A.M., Kang Y. Neurexin-neuroligin signaling in synapse development. Curr Opin Neurobiol 2007, 17(1):43-52.
13. Dalack G.W., Healy D.J., Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 1998, 155(11):1490-1501.
14. Dean C., Dresbach T. Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Trends Neurosci 2006, 29(1):21-29.
15. Dean B., Hussain T., Hayes W., Scarr E., Kitsoulis S., Hill C., et al. Changes in serotonin2A and GABAA receptors in schizophrenia. J Neurochem 1999, 72(4):1593-1599.
16. Dean C., Scholl F.G., Choih J., DeMaria S., Berger J., Isacoff E., et al. Neurexin mediates the assembly of presynaptic terminals. Nat Neurosci 2003, 6(7):708-716.
17. Gebhardt S., Theisen F.M., Haberhausen M., Heinzel-Gutenbrunner M., Wehmeier P.M., Krieg J.C., et al. Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study. J Clin Pharm Ther 2010, 35(2):207-211.
18. Graf E.R., Zhang X.Z., Jin S.X., Linhoff M.W., Craig A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004, 119(7):1013-1026.
19. Gupta M., Chauhan C., Bhatnagar P., Gupta S., Grover S., Singh P.K., et al. Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Pharmacogenomics 2009, 10(2):277-291.
20. Harrison P.J. Schizophrenia: a disorder of neurodevelopment?. Curr Opin Neurobiol 1997, 7(2):285-289.
21. Heard-Costa N.L., Zillikens M.C., Monda K.L., Johansson Å., Harris T.B., Fu M., et al. NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet 2009, 5(6):e1000539.
22. Hishimoto A., Liu Q.R., Drgon T., Pletnikova O., Walther D., Zhu X.G., et al. Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms. Hum Mol Genet 2007, 16(23):2880-2891.
23. Ichtchenko K., Nguyen T., Südhof T.C. Structures, alternative splicing, and neurexin binding of multiple neuroligins. J Biol Chem 1996, 271(5):2676-2682.
24. Kendler K.S., Diehl S.R. The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 1993, 19(2):261-285.
25. Lachman H.M., Fann C.S.J., Bartzis M., Evgrafov O.V., Rosenthal R.N., Nunes E.V., et al. Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum Mol Genet 2007, 16(11):1327-1334.
26. Lett T.A., Wallace T.J., Chowdhury N.I., Tiwari A.K., Kennedy J.L., Müller D.J. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry 2012, 17(3):242-266.
27. Lise M.F., El-Husseini A. The neuroligin and neurexin families: from structure to function at the synapse. Cell Mol Life Sci 2006, 63(16):1833-1849.
28. Liu Q.R., Drgon T., Johnson C., Walther D., Hess J., Uhl G.R. Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genes. Am J Med Genet B Neuropsychiatr Genet 2006, 141B(8):918-925.
29. McGuffin P., Owen M.J., Farmer A.E. Genetic basis of schizophrenia. Lancet 1995, 346(8976):678-682.
30. Missler M. Synaptic cell adhesion goes functional. Trends Neurosci 2003, 26(4):176-178.
31. Missler M., Südhof T.C. Neurexins: three genes and 1001 products. Trends Genet 1998, 14(1):20-26.
32. Missler M., Südhof T.C. Neurexophilins form a conserved family of neuropeptide-like glycoproteins. J Neurosci 1998, 18(10):3630-3638.
33. Missler M., Zhang W., Rohlmann A., Kattenstroth G., Hammer R.E., Gottmann K., et al. Alpha-neurexins couple Ca(2+) channels to synaptic vesicle exocytosis. Nature 2003, 423(6943):939-948.
34. Müller D.J., Kennedy J.L. Genetics of antipsychotic treatment emergent weight gain in schizophrenia. Pharmacogenomics 2006, 7(6):863-887.
35. Nam C.I., Chen L. Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter. Proc Natl Acad Sci U S A 2005, 102(17):6137-6142.
36. Novak G., Boukhadra J., Shaikh S.A., Kennedy J.L., Le Foll B. Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study. World J Biol Psychiatry 2009, 10(4 Pt 3):929-935.
37. Nussbaum J., Xu Q., Payne T.J., Ma J.Z., Huang W., Gelernter J., et al. Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. Hum Mol Genet 2008, 17(11):1569-1577.
38. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008, 40(9):1053-1055.
39. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
40. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(3):559-575.
41. Reichelt A.C., Rodgers R.J., Clapcote S.J. The role of neurexins in schizophrenia and autistic spectrum disorder. Neuropharmacology 2012, 62(3):1519-1526.
42. Riley B., Williamson R. Sane genetics for schizophrenia. Nat Med 2000, 6(3):253-255.
43. Rowen L., Young J., Birditt B., Kaur A. Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics 2002, 79(4):587-597.
44. Stephan K.E., Friston K.J., Frith C.D. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull 2009, 35(3):509-527.
45. Südhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455(7215):903-911.
46. Vaags A.K., Lionel A.C., Sato D., Goodenberger M., Stein Q.P., Curran S., et al. Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J Hum Genet 2012, 90(1):133-141.
47. Vijayan N.N., Bhaskaran S., Koshy L.V., Natarajan C., Srinivas L., Nair C.M., et al. Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population. Behav Brain Funct 2007, 3:34.
48. Wang K., Li W.D., Zhang C.K., Wang Z., Glessner J.T., Grant S.F., et al. A genome-wide association study on obesity and obesity-related traits. PLoS One 2011, 6(4):e18939.